Lords Chloro Alkali (500284) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
9 Feb, 2026Executive summary
Approved unaudited financial results for Q3 and nine months ended December 31, 2025, with limited review by statutory auditors.
Allotted 3,500,000 equity shares via conversion of warrants at Rs. 122 per share, raising Rs. 42.7 crore.
Paid-up equity share capital increased from 25,153,861 to 28,653,861 shares.
Re-appointed Managing Director for a further five-year term and approved remuneration changes for key directors.
Financial highlights
Q3 FY26 revenue from operations: Rs. 9,395.22 lakh; total income: Rs. 9,411.26 lakh.
Q3 profit before tax: Rs. 414.20 lakh; profit for the period: Rs. 356.96 lakh.
Nine months ended Dec 31, 2025: revenue from operations Rs. 29,249.36 lakh; profit for the period Rs. 2,409.72 lakh.
Basic EPS for Q3: Rs. 1.83; for nine months: Rs. 9.58.
Outlook and guidance
Board approved starting the process for an Employee Stock Option Plan (ESOP).
Latest events from Lords Chloro Alkali
- Turnaround year with 22% revenue growth, new capacity, and strong profit recovery.500284
Q4 24/2519 Jan 2026 - Q1 FY25 revenue grew 22.1% YoY, with strong EBITDA and PAT gains on higher volumes.500284
Q1 24/2527 Nov 2025 - H1 FY26 saw strong growth and margins, with major capex to boost scale and renewables.500284
Q2 25/2611 Nov 2025